Gregory M. Glenn

2015

In 2015, Gregory M. Glenn earned a total compensation of $1.9M as President, Research and Development at Novavax, a 86% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$143,500
Option Awards$1,308,000
Salary$410,000
Other$10,514
Total$1,872,014

Glenn received $1.3M in option awards, accounting for 70% of the total pay in 2015.

Glenn also received $143.5K in non-equity incentive plan, $410K in salary and $10.5K in other compensation.

Rankings

In 2015, Gregory M. Glenn's compensation ranked 4,984th out of 13,638 executives tracked by ExecPay. In other words, Glenn earned more than 63.5% of executives.

ClassificationRankingPercentile
All
4,984
out of 13,638
64th
Division
Manufacturing
1,838
out of 5,187
65th
Major group
Chemicals And Allied Products
658
out of 1,857
65th
Industry group
Drugs
524
out of 1,531
66th
Industry
Biological Products, Except Diagnostic Substances
87
out of 260
67th
Source: SEC filing on April 30, 2018.

Glenn's colleagues

We found four more compensation records of executives who worked with Gregory M. Glenn at Novavax in 2015.

2015

Stanley Erck

Novavax

Chief Executive Officer

2015

Barclay Phillips

Novavax

Chief Financial Officer

2015

John Trizzino

Novavax

SVP, Commercial Operations

2015

John Herrmann

Novavax

General Counsel

News

In-depth

You may also like